Chemoinformaics analysis of 4-HYDROXYDIHYDROAGAROFURAN
Molecular Weight | 238.371 | nRot | 0 |
Heavy Atom Molecular Weight | 212.163 | nRig | 14 |
Exact Molecular Weight | 238.193 | nRing | 3 |
Solubility: LogS | -2.959 | nHRing | 1 |
Solubility: LogP | 3.347 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 43.9906 |
nHD | 1 | BPOL | 27.8194 |
QED | 0.702 |
Synth | 5.68 |
Natural Product Likeliness | 3.095 |
NR-PPAR-gamma | 0.025 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.011 |
Pgp-sub | 0 |
HIA | 0.007 |
CACO-2 | -4.579 |
MDCK | 0.0000224 |
BBB | 0.431 |
PPB | 0.9149 |
VDSS | 1.486 |
FU | 0.0827334 |
CYP1A2-inh | 0.029 |
CYP1A2-sub | 0.944 |
CYP2c19-inh | 0.123 |
CYP2c19-sub | 0.937 |
CYP2c9-inh | 0.187 |
CYP2c9-sub | 0.202 |
CYP2d6-inh | 0.01 |
CYP2d6-sub | 0.377 |
CYP3a4-inh | 0.196 |
CYP3a4-sub | 0.873 |
CL | 10.179 |
T12 | 0.208 |
hERG | 0.028 |
Ames | 0.015 |
ROA | 0.045 |
SkinSen | 0.12 |
Carcinogencity | 0.773 |
EI | 0.229 |
Respiratory | 0.894 |
NR-Aromatase | 0.843 |
Antiviral | Yes |
Prediction | 0.880516 |